SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-21-000488
Filing Date
2021-02-17
Accepted
2021-02-17 16:07:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13g10022gtbp_02172021.htm SC 13G 215095
2 ex991to13g10022gtbp_02172021.htm EX-99.1 12080
  Complete submission text file 0000921895-21-000488.txt   228934
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-32837 | Film No.: 21644778
SIC: 2834 Pharmaceutical Preparations

Mailing Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724
Business Address 159 JENNINGS RD COLD SPRING HARBOR NY 11724 631-987-0235
BIGGER CAPITAL FUND L P (Filed by) CIK: 0001288478 (see all company filings)

IRS No.: 900131165 | State of Incorp.: DE
Type: SC 13G